FTO affects hippocampal function by regulation of BDNF processing.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30730976.
- Also identified by DOI 10.1371/journal.pone.0211937 and PMC identifier 6366932.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Initially, the function of the fat mass and obesity associated (Fto) gene seemed to be primarily the regulation of the body weight. Here we show that loss of Fto results in a hyperactivation of the hypothalamic-pituitary-adrenal (HPA) axis. In consequence, Fto-/- mice display an anxiety-like behavior and impairments in working memory. Furthermore, differentiation of neurons is affected in the hippocampus. As a cause of these impairments we identified a processing defect of the neurotrophin BDNF which is most likely the result of a reduced expression of MMP-9. Therefore, we propose FTO as a possible new target to develop novel approaches for the treatment of diseases associated with hippocampal disorders. In parallel, we also would like to make the point that any anti-obesity therapy via blocking FTO function can have negative effects on the proper function of the hippocampus.
Medical subject headings
- Alpha-Ketoglutarate-Dependent Dioxygenase FTO
- Brain-Derived Neurotrophic Factor
- Hippocampus
- Protein Processing, Post-Translational